Transcranial Direct Current Stimulation Combined With Exercise in Low Back Pain

July 19, 2022 updated by: Liane de Brito Macedo, Universidade Federal do Rio Grande do Norte

The Effects of Transcranial Direct Current Stimulation Combined With Pilates Based Exercise in the Treatment of Patients With Chronic Low Back Pain

The purpose of this study is to evaluate the effects of transcranial direct current stimulation combined with Pilates based exercise on chronic low back pain. This is a randomized clinical trial composed of two arms.

Study Overview

Detailed Description

Chronic low back pain may be associated with pathoanatomical, neurophysiological, physical, psychological and social factors. Treatments that relieve the symptoms of these patients are of great importance to improve the quality of life of these individuals. Thus, this study aims to evaluate the effects of transcranial direct current stimulation combined with Pilates based exercise on chronic low back pain. This is a randomized clinical trial that will be composed of men and women between 18 and 65 years of age, with a history of low back pain for more than 12 weeks and a minimum pain intensity equal to 3 cm on the numerical pain scale. The volunteers will be randomized into two distinct groups: stimulation + exercise group (EG - will perform a Pilates based exercise protocol combined with transcranial direct current stimulation) and sham stimulation + exercise group (SG - will perform the same exercise program combined with sham stimulation). The interventions, regardless of the group, will be carried out three times a week for four weeks. Participants will be submitted to three assessments: the first (T0) will be performed before the treatment protocols; the second (T1) will be performed after the four weeks of intervention; and the third (T2) will be a follow-up one month after the end of the treatment protocol. Pain sensation, functional performance, central sensitization, quality of life, pressure pain threshold, global impression of change, adverse events and medication use will be evaluated. For the statistical analysis, a mixed model ANOVA will be performed for the inter and intragroup comparison, with Tukey's post hoc, considering a significance level of 5%.

Study Type

Interventional

Enrollment (Anticipated)

42

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women with chronic nonspecific low back pain (for more than 12 weeks) and minimum pain intensity of 3 on numerical pain rating scale.

Exclusion Criteria:

  • diagnosis of fracture and spine pathologies, fibromyalgia, spine surgery in the last year;
  • low cognitive level assessed by the Mini Mental State Examination;
  • presence of central neurological diseases (such as Parkinson's and stroke) or psychiatric (such as depression or schizophrenia);
  • history of epileptic illness;
  • seizure history;
  • brain implants;
  • pacemaker;
  • pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Stimulation + exercise group
30-minute exercise program (based on Pilates method) combined with active transcranial direct current stimulation.
Exercise protocol + application of active direct current stimulation for 30 minutes.
SHAM_COMPARATOR: Sham stimulation + exercise group
This arm will perform the same procedures of experimental group but the stimulator will be turned off after 30 seconds and the volunteers will not receive current for the rest of the session.
Exercise protocol + application of simulation of direct current stimulation for 30 minutes. The stimulator will be turned off after 30 seconds and the volunteers will not receive current for the rest of the session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: Change from baseline in pain intensity at four weeks after intervention and 1 month of follow-up
Pain intensity measured by numerical pain rating scale (11 points scale)
Change from baseline in pain intensity at four weeks after intervention and 1 month of follow-up
Functional performance associated to back pain
Time Frame: Change from baseline in functional performance at four weeks after intervention and 1 month of follow-up
Functional performance associated with low back pain measured by Roland Morris Disability Questionnaire (24 itens)
Change from baseline in functional performance at four weeks after intervention and 1 month of follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure pain threshold
Time Frame: Change from baseline in pressure pain threshold at four weeks after intervention and 1 month of follow-up
Pressure pain threshold measured by pressure algometer.
Change from baseline in pressure pain threshold at four weeks after intervention and 1 month of follow-up
Individual quality of life
Time Frame: Change from baseline in quality of life questionnaires at four weeks after intervention and 1 month of follow-up
Measurement of quality of life using SF-36 questionnaire (36 items, divided into 8 subscales)
Change from baseline in quality of life questionnaires at four weeks after intervention and 1 month of follow-up
Patient global impression of change
Time Frame: Change from baseline in Patient global impression of change at each intervention day and at four weeks of intervention and 1 month of follow-up.
Patient global impression of change measured by a scale with seven points, where 1 is equal to no change or worse and 7 is much better.
Change from baseline in Patient global impression of change at each intervention day and at four weeks of intervention and 1 month of follow-up.
Central Sensitization
Time Frame: Change from baseline of central sensitization at four weeks after intervention and 1 month of follow-up.
Evaluation of Central Sensitization using Central Sensitization Inventory (CSI).The questionnaire is divided into two parts, the first with a score from 0 to 100 measures 25 somatic and emotional symptoms, while the second part relates to specific previous diagnoses.
Change from baseline of central sensitization at four weeks after intervention and 1 month of follow-up.
Adverse events
Time Frame: Up to 4 weeks of intervention and 1 month of follow-up.
Patient perception of any adverse event during the intervention protocol.
Up to 4 weeks of intervention and 1 month of follow-up.
Use of medications
Time Frame: Up to 4 weeks of intervention and 1 month of follow-up.
Patient declaration of medication use.
Up to 4 weeks of intervention and 1 month of follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

October 1, 2022

Primary Completion (ANTICIPATED)

August 1, 2023

Study Completion (ANTICIPATED)

December 1, 2023

Study Registration Dates

First Submitted

July 15, 2022

First Submitted That Met QC Criteria

July 19, 2022

First Posted (ACTUAL)

July 20, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Transcranial direct current stimulation

Subscribe